Published in Gastroenterology on December 01, 1996
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Acute liver failure including acetaminophen overdose. Med Clin North Am (2008) 1.10
Pregnancy and vascular liver disease. J Clin Exp Hepatol (2015) 0.88
Liver diseases in pregnancy: diseases not unique to pregnancy. World J Gastroenterol (2013) 0.84
Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty. Dig Dis Sci (2003) 0.79
Celiac disease and myointimal proliferation: a possible correlation? Case Rep Gastroenterol (2008) 0.75
Budd-Chiari Syndrome Causing Acute Liver Failure: A Multicenter Case Series. Liver Transpl (2016) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology (2000) 3.46
Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis. Arthritis Rheum (1995) 2.88
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis (1998) 2.75
Chronic diarrhea of unknown origin. Gastroenterology (1980) 2.69
Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care (2000) 2.65
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer (2013) 2.58
Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest (1995) 2.27
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer. Eur J Gastroenterol Hepatol (2005) 2.16
Peroxisomal bifunctional enzyme deficiency. J Clin Invest (1989) 2.11
Mycophenolate mofetil in patients with Crohn's disease. Am J Gastroenterol (1998) 2.08
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results. Circulation (1991) 2.06
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol (2001) 2.00
Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol (2006) 1.95
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med (1979) 1.88
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Pediatr Res (1989) 1.67
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Orthotopic liver transplantation for alcoholic liver disease. Hepatology (1990) 1.61
Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care (1995) 1.59
Visceral dissemination of herpes zoster with multiple ulcers in the upper gastrointestinal tract of an apparently immunocompetent patient. Endoscopy (2012) 1.55
The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis (2003) 1.54
Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med (1995) 1.53
Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology (1985) 1.52
Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcohol (1995) 1.51
Chromatographically purified immunoglobulin G of endemic and sporadic goiter patients stimulates FRTL5 cell growth in a mitotic arrest assay. J Clin Endocrinol Metab (1990) 1.49
Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol (2000) 1.48
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty. Eur J Clin Invest (1999) 1.47
Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias. Br J Haematol (1999) 1.42
A simple scintigraphic method for continuous monitoring of gastric emptying. Eur J Nucl Med (1993) 1.39
Reversible Huntington's disease? Lancet (1998) 1.39
Spontaneous bacterial peritonitis in a hemodialysis patient with systemic lupus erythematosus. Nephron (1993) 1.37
Inflammation-induced cholestasis. J Gastroenterol Hepatol (1999) 1.36
Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci (1995) 1.36
Intractable diarrhea. Intestinal perfusion studies and plasma VIP concentrations in patients with pancreatic cholera syndrome and surreptitious ingestion of laxatives and diuretics. Am J Dig Dis (1977) 1.36
Neuroendocrine tumours in various organ systems in a ten-year period. Eur J Surg Oncol (1995) 1.35
Colobronchial fistula: a rare complication of Crohn's colitis. Am Rev Respir Dis (1990) 1.30
Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. Gastroenterology (1980) 1.30
Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol (2007) 1.26
Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch (1999) 1.22
A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer (1995) 1.22
Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immunol (2000) 1.21
Laser photocoagulation for the treatment of acute peptic-ulcer bleeding. A randomized controlled clinical trial. N Engl J Med (1987) 1.21
Metabolic cardiomyopathies. Int J Exp Pathol (2000) 1.19
Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care (1998) 1.18
Role of Candida in antibiotic-associated diarrhea. J Infect Dis (2001) 1.17
Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch (2004) 1.16
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol (2001) 1.15
Jun and JunD-dependent functions in cell proliferation and stress response. Cell Death Differ (2010) 1.09
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br J Cancer (2010) 1.09
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis (2010) 1.08
Osteomyelitis of the hip joint associated with systemic cat-scratch disease in an adult. Eur J Clin Microbiol Infect Dis (2000) 1.08
Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am J Hum Genet (1999) 1.08
Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata. Pediatr Res (1990) 1.07
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia (2011) 1.07
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Esophageal histology in gastroesophageal reflux. Morphometric findings in suction biopsies. Am J Dig Dis (1977) 1.06
Complications of diagnostic laparoscopy in Dallas: a 7-year prospective study. Gastrointest Endosc (1984) 1.05
Aneurysms of hemodialysis access grafts: treatment with covered stents: a report of three cases. Cardiovasc Intervent Radiol (1998) 1.05
Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo. J Clin Invest (1978) 1.05
Sclerosing encapsulating peritonitis: differential diagnosis to peritoneal encapsulation and abdominal cocoon--a case report. Z Gastroenterol (1992) 1.05
Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy. J Hum Virol (1999) 1.04
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. Br J Cancer (2012) 1.04
Complete and partial agenesis of the dorsal pancreas within one family. Gastrointest Endosc (1995) 1.02
Peroxisomal fatty acid beta-oxidation in HepG2 cells. Arch Biochem Biophys (1991) 1.02
Helical CT of the small bowel with an alternative oral contrast material in patients with Crohn disease. Abdom Imaging (2003) 1.02
Pancreatic pseudocyst. Adv Intern Med (1984) 1.01
Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables. World J Surg (2000) 1.01
Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut (2002) 1.00
Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diabet Med (1995) 1.00
Presence of mycobacterial DNA in sarcoidosis. Hum Pathol (1997) 1.00
Anti-cardiolipin antibodies in patients with inflammatory bowel disease. Dig Dis Sci (1999) 0.99
Gastro-oesophageal reflux disease: correlation of subjective symptoms with 7 objective oesophageal function tests. Acta Hepatogastroenterol (Stuttg) (1976) 0.97
Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med (1983) 0.97
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol (2003) 0.96
Phlegmonous gastritis diagnosed by endoscopic snare biopsy. Am J Dig Dis (1977) 0.96
Duodenojejunal intussusception with biliary obstruction and atrophy of the pancreas. Abdom Imaging (1996) 0.96
Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm Bowel Dis (2001) 0.96
Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev (2001) 0.96
Prognostic importance of human papilloma virus typing in squamous cell papilloma of the bronchus: comparison of in situ hybridization and the polymerase chain reaction. Hum Pathol (1994) 0.96
Semiautomated quantification of hepatitis B virus DNA in a routine diagnostic laboratory. Clin Diagn Lab Immunol (2000) 0.96
Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations. Leukemia (2009) 0.95
Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. Gastroenterology (1980) 0.95
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther (2003) 0.95
Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci (1987) 0.95
Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology (1997) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Effect of neuropeptide Y on jejunal water and ion transport in humans. Gastroenterology (1991) 0.93
Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus. Diabet Med (2000) 0.93